Global Glycomics or Glycobiology Market Expected to Achieve 17% CAGR by 2029: Growth Forecast Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Glycomics or Glycobiology Market Size By 2025?
The sector encompassing glycomics and glycobiology has experienced swift expansion lately, projecting a market valuation increase from $1.85 billion in 2024 to $2.13 billion the subsequent year, reflecting a compound annual growth rate of 14.9 percent; this historical upward trend is fundamentally linked to heightened recognition regarding the roles of glycans within biological frameworks, the widening availability of databases and tools pertinent to glycans, the proliferation of cooperative research endeavors, progress in the creation and manipulation of glycans, and the successful identification of glycan-based biomarkers.

How Big Is the Glycomics or Glycobiology Market Size Expected to Grow by 2029?
Projections indicate that the scope of the glycomics or glycobiology market will expand significantly over the upcoming years, reaching a valuation of $3.99 billion by the year 2029, fueled by a compound annual growth rate (CAGR) of 17.0%. This upswing throughout the predicted timeframe is driven by factors such as the application of artificial intelligence and data analytics specifically targeting glycans, increased efforts in the development of drugs utilizing glycobiology, the incorporation of glycobiology findings into the identification of disease biomarkers, the advancement of personalized medicine approaches, and the creation of therapeutics based on glycans. Key developments anticipated across this period encompass increased cooperation across various scientific disciplines, deeper understanding of glycosylation variations within disease processes, the emergence of novel, highly specific medicine and tailored treatments, improvements in the instruments used for glycan analysis, and the role of glycans in developing immunotherapies and vaccines.

View the full report here:
https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Which Key Market Drivers Powering Glycomics or Glycobiology Market Expansion and Growth?
Anticipation of expanding needs for therapeutic agents addressing numerous serious, long-duration health conditions is forecast to stimulate the progression of the glycomics or glycobiology sector in the future; these long-term ailments are typically manageable but lack a complete cure. Research within glycomics investigates alterations in glycosylation and its roles, proving instrumental in formulating drugs and corresponding treatments for various debilitating, chronic illnesses. For example, as noted in the American Cancer Society's scientific publication, Cancer Facts and Figures 2022-2024, the population of cancer survivors, an example of a chronic condition, was projected to rise from 22.5 million individuals in 2022 to an estimated 26 million by the year 2040, thereby showing how the escalating requirement for medications targeting these persistent health issues fuels the expansion of the market dedicated to glycomics or glycobiology.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8749&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Glycomics or Glycobiology Market?
A prominent movement within the glycomics or glycobiology market involves significant capital allocation towards research and development endeavors. Leading research bodies are injecting funds into glycobiology research facilities, specifically targeting advancements in the field of glycomics or glycobiology. As an illustration, in August of 2022, Griffith University, which is situated in Australia and hosts the Institute for Glycomics, inaugurated the ACRF International Centre for Cancer Glycomics, bolstered by a substantial $2.6 million grant from ACRF and focused entirely on decoding cancer's glycocode. This center represents a singular establishment where a deeper comprehension of the glycocode is anticipated to pave the way for new breakthroughs and clinical results beneficial for enhancing the quality of life for individuals battling cancer.

What Are the Emerging Segments in the Glycomics or Glycobiology Market?
The glycomics or glycobiologymarket covered in this report is segmented -

1) By Product: Enzymes; Kits; Reagents And Chemicals; Instruments; Carbohydrates
2) By Application: Drug Discovery And Development; Disease Diagnostics; Other Applications
3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Clinical Laboratories

Subsegments:
1) By Enzymes: Glycosidases; Glycosyltransferases; Sialidases
2) By Kits: Glycan Analysis Kits; Glycobiology Research Kits
3) By Reagents And Chemicals: Monosaccharides; Oligosaccharides; Chemical Modifiers
4) By Instruments: Mass Spectrometers; Chromatography Systems; Imaging Systems
5) By Carbohydrates: Natural Carbohydrates; Synthetic Carbohydrates

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8749&type=smp

Who Are the Global Leaders in the Glycomics or Glycobiology Market?
Major companies operating in the glycomics or glycobiology market are Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., R&D Systems Inc.

Which are the Top Profitable Regional Markets for the Glycomics or Glycobiology Industry?
North America was the largest region in the glycomics or glycobiology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8749

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.